{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-11-03",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "60492-0075",
      "generic_name": "Botulism Antitoxin Heptavalent",
      "labeler_name": "Emergent BioSolutions Canada Inc",
      "brand_name": "BAT",
      "active_ingredients": [
        {
          "name": "EQUINE BOTULINUM NEUROTOXIN A IMMUNE FAB2",
          "strength": "4500 [iU]/10mL"
        },
        {
          "name": "EQUINE BOTULINUM NEUROTOXIN B IMMUNE FAB2",
          "strength": "3300 [iU]/10mL"
        },
        {
          "name": "EQUINE BOTULINUM NEUROTOXIN C IMMUNE FAB2",
          "strength": "3000 [iU]/10mL"
        },
        {
          "name": "EQUINE BOTULINUM NEUROTOXIN D IMMUNE FAB2",
          "strength": "600 [iU]/10mL"
        },
        {
          "name": "EQUINE BOTULINUM NEUROTOXIN E IMMUNE FAB2",
          "strength": "5100 [iU]/10mL"
        },
        {
          "name": "EQUINE BOTULINUM NEUROTOXIN F IMMUNE FAB2",
          "strength": "3000 [iU]/10mL"
        },
        {
          "name": "EQUINE BOTULINUM NEUROTOXIN G IMMUNE FAB2",
          "strength": "600 [iU]/10mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "60492-0075-2",
          "description": "6 VIAL, GLASS in 1 CARTON (60492-0075-2)  / 50 mL in 1 VIAL, GLASS (60492-0075-1)",
          "marketing_start_date": "20130301",
          "sample": false
        },
        {
          "package_ndc": "60492-0075-4",
          "description": "1 VIAL, GLASS in 1 CARTON (60492-0075-4)  / 50 mL in 1 VIAL, GLASS (60492-0075-1)",
          "marketing_start_date": "20130301",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "BLA",
      "dosage_form": "LIQUID",
      "spl_id": "c49e701b-f65d-4493-85f8-21a2e8d8974d",
      "product_type": "PLASMA DERIVATIVE",
      "route": [
        "INTRAVENOUS"
      ],
      "marketing_start_date": "20130301",
      "product_id": "60492-0075_c49e701b-f65d-4493-85f8-21a2e8d8974d",
      "application_number": "BLA125462",
      "brand_name_base": "BAT"
    }
  ]
}